SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-157374
Filing Date
2024-06-07
Accepted
2024-06-07 16:15:59
Documents
14
Period of Report
2024-06-05
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d837571d8k.htm   iXBRL 8-K 45023
  Complete submission text file 0001193125-24-157374.txt   207794

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nams-20240605.xsd EX-101.SCH 3568
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nams-20240605_def.xml EX-101.DEF 14183
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nams-20240605_lab.xml EX-101.LAB 23099
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nams-20240605_pre.xml EX-101.PRE 15031
17 EXTRACTED XBRL INSTANCE DOCUMENT d837571d8k_htm.xml XML 5852
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41562 | Film No.: 241029638
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)